Health TrialsbyHealthPanel

Immunochemotherapy

3

Review clinical trials related to Immunochemotherapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

This is an open-label, prospective, single-arm, multicenter study designed to evaluate the efficacy and safety of MTX plus pirtobrutinib combined with routinely-used clinical chemoimmunotherapy regimens in patients with DLBCL and central nervous system (CNS) involvement.

Participants needed: 24
Trial details
Phase: Phase 2Age: 14-80Biological sex: AllType: InterventionalSponsor: Pengpeng XuUpdated: Sep 11, 2026Locations: 1
Eligibility criteria

Bone marrow function: absolute neutrophil count (ANC) ≥ 1.0 × 10⁹/L; platelet co... [+4]

Contraindication to any drug in the treatment regimen. [+6]

Read more
Status: Recruiting

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

Efficacy evaluation of camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery.

Participants needed: 59
Trial details
Phase: Phase 2Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Women's Hospital School Of Medicine Zhejiang UniversityUpdated: Dec 18, 2025Locations: 1
Eligibility criteria

Patients with cervical cancer staged FIGO2018 IIIC1p or IIIC2p after radical sur... [+2]

Positive parametrium or surgical margin; [+4]

Read more
Status: Not yet recruiting

Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma

Previously untreated patients with follicular lymphoma are treated with the ZGCVP regimen (zanubrutinib, obinutuzumab, cyclophosphamide, vindesine, prednisolone) for 6 cycles.

Participants needed: 58
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Zhejiang Cancer HospitalUpdated: Apr 15, 2025Locations: 1
Eligibility criteria

Participate in the clinical study voluntarily, fully understand and be informed... [+12]

Central nervous system involvement secondary to lymphoma. [+11]

Read more